What Braidwell LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1920938 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 2.7M |
| −66.7% |
| $84.1M |
| 3.5% |
EWTXEdgewise Therapeutics, Inc. | 2.1M | +3.6% | $84M | 3.5% |
ATECAlphatec Holdings, Inc. | 7.2M | +10.7% | $74.6M | 3.1% |
IRTCiRhythm Holdings, Inc. | 640.6K | −2.1% | $72.8M | 3% |
ALPHATEC HLDGS INCNOTE 0.750% 3/1 | 69.1M | New | $69.3M | 2.9% |
HNGEHinge Health, Inc. | 655.3K | −50.7% | $63.7M | 2.6% |
SYRESpyre Therapeutics, Inc. | 714K | −18.8% | $63.6M | 2.6% |
XENEXenon Pharmaceuticals Inc. | 1.7M | +51.0% | $63.5M | 2.6% |
NEONeogenomics Inc | 3.3M | −31.9% | $61.5M | 2.6% |
GKOSGlaukos Corp | 343.9K | −41.9% | $56.5M | 2.3% |
VERAVera Therapeutics, Inc. | 1.7M | +205.8% | $55.8M | 2.3% |
TMDXTransMedics Group, Inc. | 654.2K | +7.3% | $54.6M | 2.3% |
ISRGIntuitive Surgical Inc | 126K | +79.6% | $51.2M | 2.1% |
AVAHAveanna Healthcare Holdings, Inc. | 3.9M | +26.3% | $48M | 2% |
NBIXNeurocrine Biosciences Inc | 336.6K | +0.1% | $47.7M | 2% |
DNTHDianthus Therapeutics, Inc. | 518.4K | −12.8% | $45.6M | 1.9% |
BTSGBrightSpring Health Services, Inc. | 802.5K | +34.5% | $45.5M | 1.9% |
GENBGenerate Biomedicines, Inc. | 3M | −9.8% | $44.5M | 1.8% |
MRVIMaravai Lifesciences Holdings, Inc. | 5.5M | −36.8% | $42.2M | 1.7% |
KRYSKrystal Biotech, Inc. | 114.1K | −11.6% | $37.9M | 1.6% |
ACHCAcadia Healthcare Company, Inc. | 1.4M | +18.5% | $37.2M | 1.5% |
DMRADamora Therapeutics, Inc. | 1.7M | New | $37.2M | 1.5% |
ALMRAlamar Biosciences, Inc. | 1.1M | ±0% | $36.9M | 1.5% |
KYMRKymera Therapeutics, Inc. | 300.6K | −20.5% | $33.6M | 1.4% |
NVCTNuvectis Pharma, Inc. | 1.6M | New | $33.2M | 1.4% |
CLYMClimb Bio, Inc. | 2.9M | +2.4% | $32.8M | 1.4% |
INSPInspire Medical Systems, Inc. | 464.5K | −31.5% | $32.2M | 1.3% |
DHRDanaher Corp | 141.5K | −6.1% | $31.4M | 1.3% |
MAZEMaze Therapeutics, Inc. | 1.1M | +0.9% | $31.2M | 1.3% |
HUMHumana Inc | 81.4K | −28.9% | $31.1M | 1.3% |
GLUEMonte Rosa Therapeutics, Inc. | 2.5M | +3.0% | $30.1M | 1.3% |
TEVATeva Pharmaceutical Industries Ltd | 753.5K | New | $29.8M | 1.2% |
TMOThermo Fisher Scientific Inc. | 41.7K | −53.4% | $28.1M | 1.2% |
IMCRImmunocore Holdings plc | 906.1K | +73.8% | $27.4M | 1.1% |
NKTRNektar Therapeutics | 443.6K | −6.3% | $26.9M | 1.1% |
ORKAOruka Therapeutics, Inc. | 319.7K | +14.9% | $26.6M | 1.1% |
BSXBoston Scientific Corp | 587.6K | ±0% | $25.6M | 1.1% |
NTRANatera, Inc. | 59.9K | −24.7% | $24.8M | 1% |
EOLSEvolus, Inc. | 3.1M | −2.3% | $24.7M | 1% |
AVTXAvalo Therapeutics, Inc. | 1.6M | −1.2% | $24.7M | 1% |
KIDSOrthopediatrics Corp | 1.1M | ±0% | $24.5M | 1% |
RYTMRhythm Pharmaceuticals, Inc. | 255.8K | −32.9% | $24.4M | 1% |
DRUGBright Minds Biosciences Inc. | 483.8K | ±0% | $24.1M | 1% |
MBXMBX Biosciences, Inc. | 399K | −43.9% | $23.4M | 1% |
CRVSCorvus Pharmaceuticals, Inc. | 1.9M | −9.2% | $22.2M | 0.9% |
RGENRepligen Corp | 111.5K | −37.0% | $21.4M | 0.9% |
AVLNAvalyn Pharma Inc. | 744.5K | −7.1% | $21.2M | 0.9% |
GHRSGH Research PLC | 902.8K | +335.6% | $21.2M | 0.9% |
GHGuardant Health, Inc. | 117.9K | −20.3% | $21M | 0.9% |
NRIXNurix Therapeutics, Inc. | 871.1K | −32.3% | $20.7M | 0.9% |
CSTLCastle Biosciences Inc | 502.5K | New | $17.9M | 0.7% |
NEOGENOMICS INCNOTE 0.250% 1/1 | 18M | New | $16.9M | 0.7% |
OVIDOvid Therapeutics Inc. | 6.6M | +11.2% | $16.4M | 0.7% |
SYKStryker Corp | 49.6K | New | $13.6M | 0.6% |
ORICOric Pharmaceuticals, Inc. | 991K | −18.4% | $13.3M | 0.6% |
SEPNSepterna, Inc. | 328.2K | New | $12.8M | 0.5% |
COGTCogent Biosciences, Inc. | 400.9K | New | $12.8M | 0.5% |
ANLAdlai Nortye Group Ltd. | 795.2K | ±0% | $12.7M | 0.5% |
LFSTLifeStance Health Group, Inc. | 975.4K | New | $11.7M | 0.5% |
ZURAZura Bio Ltd | 2.7M | −33.3% | $11M | 0.5% |
SRZNSurrozen, Inc. | 335.2K | −14.2% | $10.8M | 0.4% |
ETRAElectra Therapeutics, Inc. | 905.7K | New | $10.2M | 0.4% |
OCSOculis Holding AG | 1.1M | +28.1% | $10M | 0.4% |
SPTXSeaport Therapeutics, Inc. | 481.5K | −3.7% | $9.7M | 0.4% |
HLXCHelix Acquisition Corp. III | 900K | ±0% | $9.5M | 0.4% |
DGXQuest Diagnostics Inc | 40.4K | −6.5% | $9.4M | 0.4% |
ACRSAclaris Therapeutics, Inc. | 1.8M | −18.1% | $9.2M | 0.4% |
TECXTectonic Therapeutic, Inc. | 371.1K | −37.8% | $8.6M | 0.4% |
IONSIonis Pharmaceuticals Inc | 176.5K | +51.1% | $7.9M | 0.3% |
ELVElevance Health, Inc. | 19.4K | −64.0% | $7.6M | 0.3% |
YARWYarrow Bioscience, Inc. | 331.4K | New | $7.5M | 0.3% |
AMANAmanat Acquisition Corp. | 700K | ±0% | $7.5M | 0.3% |
BIOABioAge Labs, Inc. | 1M | ±0% | $7.3M | 0.3% |
XFORX4 Pharmaceuticals, Inc | 2.3M | −19.8% | $6.8M | 0.3% |
VORVor Biopharma Inc. | 319.3K | −44.3% | $6.1M | 0.3% |
IMUXImmunic, Inc. | 645.1K | +0.0% | $6M | 0.2% |
ADRXADARx Pharmaceuticals, Inc. | 300K | New | $6M | 0.2% |
QUREuniQure N.V. | 226.7K | −24.9% | $5.5M | 0.2% |
RACCResearch Alliance Corp III | 400K | ±0% | $4.3M | 0.2% |
JTTTJATT III Acquisition Corp | 350K | New | $3.9M | 0.2% |
ATTOAttovia Therapeutics, Inc. | 225K | New | $3.9M | 0.2% |
RACDResearch Alliance Corp IV | 300K | New | $3.6M | 0.1% |
CGONCG Oncology, Inc. | 41.1K | New | $2.9M | 0.1% |
JATTJATT II Acquisition Corp. | 250K | ±0% | $2.8M | 0.1% |
LUNGPulmonx Corp | 752.5K | ±0% | $1.4M | 0.1% |
KRSAKorsana Biosciences, Inc. | 43K | New | $1.4M | 0.1% |
TENXTenax Therapeutics, Inc. | 584.4K | ±0% | $1.1M | 0.1% |